Bio-Rad Laboratories, Inc. BIO posted first-quarter 2025 adjusted earnings per share (EPS) of $2.54, which surpassed the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Dogecoin (DOGE), the meme-inspired cryptocurrency that gained fame for its viral rallies, is once again on investors’ radar.

Dogecoin trades at $0.17 with bullish technical patterns forming, while analysts predict potential rises to $0.50 if it ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Earendil Labs will collaborate with Sanofi SA in a $1.8 billion license deal. Earendil, which specializes in artificial intelligence-based R&D for biologics, is getting $125 million up front and $50 ...

Investors should monitor key support levels on gold's chart around $3,170, $3,048, $2,955, and $2,858. Gold (XAUUSD) will remain in focus after surging to record highs last week as investors ...

South African rand: Weakened by 4.4 percent over the past week, reaching R19.75, its weakest level in two years. A recession is a period of significant economic decline, typically defined as two ...

RBC Capital lowered the firm’s price target on Bio-Rad (BIO) to $409 from $430 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results in the Life ...